Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYO6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SEMA3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C6orf106 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARCKS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPAG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
C7orf49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TP53RK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIBADH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAPPC6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUS4L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHBDD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on